down arrow

Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,464.00
47.7 (3.37%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 15.86 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,449.251,488.80

52 Week

1,310.051,702.00
Valuation
Technical
Day's Volume

CASH

15.86 lacs (18.54%) Volume

Shareholding (Dec 2024)

FII

26.65%

Held by 952 FIIs

DII

27.72%

Held by 96 DIIs

Promoter

29.19%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Healthy long term growth as Operating profit has grown by an annual rate 21.54%

 
3

The company has declared Positive results for the last 7 consecutive quarters

4

Stock is technically in a Bearish range

5

With ROE of 16.3, it has a Attractive valuation with a 4 Price to Book Value

6

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 118,235 Cr (Large Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.92%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

16.28%

stock-summary
Price to Book

4.03

Revenue and Profits (1 Year):
Net Sales:
7,073 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,571 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.92%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-8.23%
0%
-8.23%
1 Year
2.92%
0.92%
3.84%
2 Years
61.38%
2.31%
63.69%
3 Years
43.03%
2.88%
45.91%
4 Years
65.93%
3.58%
69.51%
5 Years
152.63%
4.93%
157.56%

Latest dividend: 13 per share ex-dividend date: Aug-02-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.77%
EBIT Growth (5y)
21.54%
EBIT to Interest (avg)
44.00
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.95
Tax Ratio
23.96%
Dividend Payout Ratio
25.47%
Pledged Shares
0
Institutional Holding
54.37%
ROCE (avg)
19.44%
ROE (avg)
13.44%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
4.03
EV to EBIT
18.83
EV to EBITDA
15.87
EV to Capital Employed
4.65
EV to Sales
4.06
PEG Ratio
0.90
Dividend Yield
0.92%
ROCE (Latest)
23.85%
ROE (Latest)
16.28%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 40 Schemes (20.46%)

FIIs

Held by 952 FIIs (26.65%)

Promoter with highest holding

Yusuf Khwaja Hameid (18.67%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Manufacturing Fund (5.11%)

Individual Investors Holdings

14.29%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.31% vs 5.33% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 20.57% vs 10.61% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,072.97",
          "val2": "7,051.02",
          "chgp": "0.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,988.92",
          "val2": "1,885.59",
          "chgp": "5.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.64",
          "val2": "15.40",
          "chgp": "-4.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,570.51",
          "val2": "1,302.53",
          "chgp": "20.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.57%",
          "val2": "27.09%",
          "chgp": "1.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 5.67% vs 16.10% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 16.63% vs 44.15% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,744.96",
          "val2": "13,007.04",
          "chgp": "5.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,601.39",
          "val2": "3,227.66",
          "chgp": "11.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.35",
          "val2": "42.19",
          "chgp": "-20.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,480.17",
          "val2": "2,126.61",
          "chgp": "16.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.51%",
          "val2": "25.10%",
          "chgp": "1.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.16% vs 15.26% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 27.28% vs 39.81% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20,817.93",
          "val2": "19,610.85",
          "chgp": "6.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,590.31",
          "val2": "4,975.19",
          "chgp": "12.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "47.99",
          "val2": "72.29",
          "chgp": "-33.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-194.82",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,050.68",
          "val2": "3,182.51",
          "chgp": "27.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.85%",
          "val2": "25.37%",
          "chgp": "1.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 13.28% vs 4.55% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 47.10% vs 11.33% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25,774.09",
          "val2": "22,753.12",
          "chgp": "13.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,291.05",
          "val2": "5,026.97",
          "chgp": "25.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "89.88",
          "val2": "109.54",
          "chgp": "-17.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-194.82",
          "val2": "-182.42",
          "chgp": "-6.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,121.55",
          "val2": "2,801.91",
          "chgp": "47.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.72%",
          "val2": "22.37%",
          "chgp": "2.35%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
7,072.97
7,051.02
0.31%
Operating Profit (PBDIT) excl Other Income
1,988.92
1,885.59
5.48%
Interest
14.64
15.40
-4.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,570.51
1,302.53
20.57%
Operating Profit Margin (Excl OI)
28.57%
27.09%
1.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 0.31% vs 5.33% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 20.57% vs 10.61% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
13,744.96
13,007.04
5.67%
Operating Profit (PBDIT) excl Other Income
3,601.39
3,227.66
11.58%
Interest
33.35
42.19
-20.95%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,480.17
2,126.61
16.63%
Operating Profit Margin (Excl OI)
26.51%
25.10%
1.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 5.67% vs 16.10% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 16.63% vs 44.15% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
20,817.93
19,610.85
6.16%
Operating Profit (PBDIT) excl Other Income
5,590.31
4,975.19
12.36%
Interest
47.99
72.29
-33.61%
Exceptional Items
0.00
-194.82
100.00%
Consolidate Net Profit
4,050.68
3,182.51
27.28%
Operating Profit Margin (Excl OI)
26.85%
25.37%
1.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.16% vs 15.26% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 27.28% vs 39.81% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
25,774.09
22,753.12
13.28%
Operating Profit (PBDIT) excl Other Income
6,291.05
5,026.97
25.15%
Interest
89.88
109.54
-17.95%
Exceptional Items
-194.82
-182.42
-6.80%
Consolidate Net Profit
4,121.55
2,801.91
47.10%
Operating Profit Margin (Excl OI)
24.72%
22.37%
2.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 13.28% vs 4.55% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 47.10% vs 11.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cipla Ltd. stock-summary
stock-summary
Cipla Ltd.
Large Cap
Pharmaceuticals & Drugs
Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
Company Coordinates stock-summary
Company Details
Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel Mumbai Maharashtra : 400013
stock-summary
Tel: 91-22-24826000
stock-summary
http://www.cipla.com
stock-summary
cosecretary@cipla.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."